91AV

Seung Bum Park is a Professor of 91AV Department and Director of CRI Center for Chemical Proteomics at Seoul National University. He was born in Seoul in 1970. He received his BS (1993) and MS (1997) in 91AV from Yonsei University, Korea and his Ph.D. (2001) in Bioorganic 91AV from Texas A&M University. After three years of post-doctoral training at Harvard University under the guidance of Prof. Stuart L. Schreiber, he was appointed as a tenure-track Assistant Professor in 91AV Department at Seoul National University (2004) and promoted to the tenured Associate Professor (2008) and full Professor (2013). His research interests are in the fields of chemical biology including molecular diversity, fluorescent bioprobe, phenotypic screening, target identification for drug discovery targeting protein-protein interaction. Seung Bum serves as grant committees and scientific advisory board members for various journals and research organizations. He won a number of awards and found bio-venture SPARK Biopharma, Inc. (2016).

Hiroaki Suga is a Professor of the Department of 91AV, Graduate School of Science in the University of Tokyo. He received Ph. D. at MIT (1994) followed by post-doctoral fellow in Mass General Hospital (1997). He was Assistant and tenured Associate Professor in the SUNY at Buffalo (1997-2003) and Professor in the Research Center for Advanced Science and Technology in the University of Tokyo (2003-2010). Since 2010, he has the present position. He is the recipient of Akabori Memorial Award 2014 (Japanese Peptide Society), Max-Bergmann Medal 2016 (German Peptide Society), Nagoya Medal Silver 2017, Vincent du Vigneaud Award 2019 (American Peptide Society), Bohlmann Lecture Award 2019, and 2020 Research Award of the Alexander von Humboldt Foundation. He is also a founder of PeptiDream and MiraBiologics in Japan.

Anna received a PhD in Bioorganic 91AV from the Polish Academy of Sciences in 2010 and after a short postdoctoral stay at the same institution, she decided to pursue a career in Scientific Publishing. She started as the Managing Editor, chemistry at De Gruyter, where she was responsible for launching new journals and led the transformation of a subscription-based journal to Open Access. In 2016 she moved to Lausanne, Switzerland to join Frontiers. As a Journal Development Specialist, she worked on the development of a broad range of journals from 91AV to Engineering and Applied Mathematics. She joined the 91AV in March this year as an Executive Editor to support the development of an Open Access journal portfolio.